Electro-Optical Sciences, Inc. to Present at Upcoming Investor Conferences
Published: Nov 12, 2009
IRVINGTON, NY--(Marketwire - November 11, 2009) - Electro-Optical Sciences Inc. ("EOS") (NASDAQ: MELA) today announced that Joseph V. Gulfo, MD, President and Chief Executive Officer, will present at the following investor conferences in November and December:
-- The Lazard Capital Markets 6th Annual Healthcare Conference, November 17-18, 2009 at the St. Regis Hotel in New York City. Dr. Gulfo is scheduled to present on Tuesday, November 17, 2009 at 3:40 pm ET. -- The 21st Annual Piper Jaffray Health Care Conference, December 1-2, 2009 at the New York Palace Hotel in New York City. Dr. Gulfo is scheduled to present on Wednesday, December 2, 2009 at 8:00 am ET.
To access live webcasts of these presentations, visit www.eosciences.com. A replay of this presentation will be available on the company's website for thirty days following the presentation.
About Electro-Optical Sciences
Electro-Optical Sciences is a medical technology company focused on developing MelaFind®, a non-invasive and objective computer vision system intended to aid in the early detection of melanoma. EOS designed MelaFind® to assist in the evaluation of pigmented skin lesions, including atypical moles, which have one or more clinical or historical characteristics of melanoma, before a final decision to biopsy has been rendered. MelaFind® acquires and displays multi-spectral (from blue to near infrared) digital images of pigmented skin lesions and uses automatic image analysis and statistical pattern recognition to help identify lesions to be considered for biopsy to rule out melanoma.
Although the MelaFind® PMA is subject to the FDA's expedited review procedures, EOS cannot predict either the timing of the FDA's decision on the PMA application or the outcome. FDA approval is required prior to marketing MelaFind® in the United States.
For more information on EOS, visit www.eosciences.com.
This press release includes "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to our plans, objectives, expectations and intentions and other statements that contain words such as "expects," "contemplates," "anticipates," "plans," "intends," "believes" and variations of such words or similar expressions that predict or indicate future events or trends, or that do not relate to historical matters. These statements are based on our current beliefs or expectations and are inherently subject to significant uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved. Actual results may differ materially from our beliefs or expectations due to economic, business, competitive, market and regulatory factors.
For further information contact:
Lazar Partners Ltd.